- Investor's Business Daily•yesterday
Big U.S. pharmas AbbVie and Merck traded higher and flat, respectively, after reporting positive Q2 results, while France's Sanofi headed lower.
Looking at the earnings posted by Merck & Co. (MRK), I could not help but compare and contrast them with what Sanofi (SNY) said this morning. Like Sanofi had with Lantus, Merck has a mega-blockbuster with Januvia. Just as Lantus was getting long in the tooth and facing patent expiration